DEKA Biosciences
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors (NCT05704985) | DEKA Biosciences | 2023-04-03 |
Track DEKA Biosciences automatically
Every clearance here is in the API, with alerts when new ones post.